LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Languages: English
Types: Article
Subjects: RC

Classified by OpenAIRE into

mesheuropmc: cardiovascular diseases
Due to their similar aetiologies, cardiovascular disease (CVD) and erectile dysfunction (ED) are closely linked, with the prevalence of ED being approximately 75% for individuals at high risk of CVD. ED can have a detrimental effect on quality of life not only for the individual but also his sexual partner which in turn impacts upon their intimate relationship. Some CVD medications have been found to have a negative effect on erectile function and therefore act as an influential factor for the cessation of important CVD medication. Low adherence to CVD medication has been linked to increased health costs, hospitalizations and importantly, a higher risk of mortality. Research has shown that men find it difficult to seek medical help in relation to ED which is also compounded by the notion that health care providers do not address sexual issues adequately. Patients' beliefs about CVD medication are modifiable and therefore an opportunity exists not only for health care providers to facilitate discussions in relation to ED and medication adherence but also encompass an opportunity to increase adherence to CVD medication through intervention.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Aggarwal, B., and Mosca, L. (2010). Lifestyle and psychosocial risk factors predict nonadherence to medication. Annals of Behavioral Medicine, 40(2), 228-233.
    • Baroletti, S., and Dell'Orfano, H. (2010). Medication adherence in cardiovascular disease.
    • Circulation, 121(12), 1455-1458.
    • Baumhäkel, M., Werner, N., Böhm, M., & Nickenig, G. (2006). Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease.
    • European heart journal, 27(18), 2184-2188.
    • Baumhäkel, M., Schlimmer, N., Kratz, M., Hacket, G., Jackson, G., & Böhm, M. (2011).
    • Cardiovascular risk, drugs and erectile function-a systematic analysis. International journal of clinical practice, 65(3), 289-298.
    • Benson, J., & Britten, N. (2002). Patients' decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ, 325(7369), 873.
    • Blumentals, W. A., Gomez-Caminero, A., Joo, S., & Vannappagari, V. (2004). Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. International journal of impotence research, 16(4), 350-353.
    • Byrne, M., Doherty, S., Murphy, A.W., McGee, H.M., Jaarsma, T. (2013). Communicating about sexual concerns within cardiac health services: do service providers and service users agree? Patient Education and Counseling, 92(3), 398-403.
    • Cappelleri, J. C. and Rosen, R. C. (2005) The Sexual Health Inventory for Men (SHIM) : A 5- year review of research and clinical experience. International Journal of Impotence Research 17 : 307-19 Dong, J. Y., Zhang, Y. H., & Qin, L. Q. (2011). Erectile Dysfunction and Risk of Cardiovascular DiseaseMeta-Analysis of Prospective Cohort Studies. Journal of the American College of Cardiology, 58(13), 1378-1385.
    • Feldman, H. A., Goldstein, I., Hatzichristou, D. G., Krane, R. J., & McKinlay, J. B. (1994).
    • Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. The Journal of urology, 151(1), 54.
    • Fergus, I. V. (2009). Antihypertensive pharmacotherapy: adverse effects of medications promote nonadherence. Journal of the CardioMetabolic Syndrome, 4(1), E1-E3.
    • Fisher, W. A., Rosen, R. C., Eardley, I., Sand, M., & Goldstein, I. (2005). Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study. The journal of sexual medicine, 2(5), 675-684.
    • Friedman, S. (2000). Cardiac disease, anxiety, and sexual functioning. The American journal of cardiology, 86(2), 46-50.
    • Goldstein, I. (2000). The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction. The American journal of cardiology, 86(2), 41-45.
    • Grégoire, J. P., Moisan, J., Guibert, R., Ciampi, A., & Milot, A. (2006). Predictors of selfreported noncompliance with antihypertensive drug treatment: A prospective cohort study.
    • Canadian Journal of Cardiology, 22(4), 323-329.
    • Günzler, C., Kriston, L., Harms, A., & Berner, M. M. (2009). Association of sexual functioning and quality of partnership in patients in cardiovascular rehabilitation-A gender perspective. The journal of sexual medicine, 6(1), 164-174.
    • (2005). Identification of psychosocial factors of noncompliance in hypertensive patients.
    • Journal of human hypertension, 20(1), 23-29.
    • Hodges, L. D., Kirby, M., Solanki, J., O'Donnell, J., & Brodie, D. A. (2007). The temporal relationship between erectile dysfunction and cardiovascular disease. International journal of clinical practice, 61(12), 2019-2025.
    • Jackson, G. (2013). Erectile dysfunction and cardiovascular disease. Arab Journal of Urology,11(3), 212-216.
    • H. N. (2000). Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. The Journal of urology, 163(2), 460-463.
    • Kirby, M., Jackson, G., Betteridge, J., & Friedli, K. (2001). Is erectile dysfunction a marker for cardiovascular disease?. International journal of clinical practice, 55(9), 614.
    • Kloner, R. A. (1993). NIH Consensus Development Panel on Impotence. JAMA, 270(1), 83-90.
    • Knapton, M. (2012). Cardiovascular disease in primary care: concordance and risk reduction.
    • The British Journal of General Practice, 62(599), 284.
    • Kriston, L., Günzler, C., Agyemang, A., Bengel, J., & Berner, M. M. (2010). Effect of Sexual Function on Health‐Related Quality of Life Mediated by Depressive Symptoms in Cardiac Rehabilitation. Findings of the SPARK Project in 493 Patients. The journal of sexual medicine, 7(6), 2044-2055.
    • (2005). Erectile dysfunction and its influence on quality of life in patients with essential hypertension. American journal of hypertension, 18(3), 427-430.
    • Steggall, M. (2012). Pharmacological management of erectile dysfunction. Nurse Prescribing, 10(7), 339-344.
    • Vlachopoulos, C., Jackson, G., Stefanadis, C., & Montorsi, P. (2013). Erectile dysfunction in the cardiovascular patient. European heart journal,34:2034-46 Voils, C. I., Sandelowski, M., Dahm, P., Blouin, R., Bosworth, H. B., Oddone, E. Z., & Steinhauser, K. E. (2008). Selective adherence to antihypertensive medications as a patientdriven means to preserving sexual potency. Patient preference and adherence, 2, 201.
  • No related research data.
  • No similar publications.

Share - Bookmark

Download from

Cite this article